-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Trainee Didactic Session: A Road Less Traveled - Careers Outside of Academia

Symposia: Trainee Didactic Sessions Program: Trainee Activities and Services
Hematology Disease Topics & Pathways:
Sunday, December 10, 2023: 11:15 AM-12:15 PM
Room 33 (San Diego Convention Center)
Ifeyinwa Osunkwo, MD, MPH, Ify Osunkwo MD, MPH, formerly Director SCD Enterprise Atrium Health; Currently Chief Patient Officer / SVP Forma therapeutics
Osunkwo: Novo Nordisk: Consultancy, Current Employment, Current equity holder in publicly-traded company, Honoraria; Forma Therapeutics: Consultancy, Ended employment in the past 24 months, Honoraria; Global Blood Therapeutics: Consultancy, Speakers Bureau; Novartis: Consultancy, Honoraria; Takeda: Consultancy; Cheisi: Consultancy; Emmaus: Consultancy, Speakers Bureau; Agios: Consultancy; Acceleron: Consultancy.

Amber M Yates, MD

Global Medical Affairs, Agios Pharmaceuticals, Cambridge, MA

Timothy Kubal, MD, MBA

Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL